Latest News
Press Releases
October 29, 2020
IAVI Announces Start of Clinical Trial of Next-Generation HIV Vaccine Candidate
October 27, 2020Support from the U.S. Department of Defense Will Accelerate Progress on Vaccine Candidate for COVID-19, IAVI Says
October 22, 2020IAVI, Merck KGaA, Darmstadt, Germany, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access
August 10, 2020IAVI and Wellcome issue a global call to action: Monoclonal antibodies for COVID-19 and other diseases could save millions of lives
July 9, 2020IAVI and Scripps Research Join Efforts with NIH to Expedite Development of Globally Accessible and Affordable HIV Antibody Combination Products
Features
October 23, 2020
Progress Toward Global Access to Affordable Antibodies
October 8, 2020What are monoclonal antibodies, and can they treat COVID-19?
September 28, 2020International Journal of Epidemiology publishes cohort profile of IAVI’s longitudinal HIV infection studies in Africa
September 22, 2020What we learned from our “Ask the Experts: COVID-19” webinar series
September 18, 2020International Snakebite Awareness Day 2020 – Introducing the SRPNTS Consortium
Media Contacts
North America
Rose Catlos
+1 212 847 1049
RCatlos@iavi.org
